The Company is currently working to develop its scientific and medical advisory board.
Algernon Pharmaceuticals is a clinical stage pharmaceutical development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and inflammatory bowel disease (IBD).
Sign up for our News Releases
Suite 915 – 700 West Pender Street
Vancouver, BC, Canada • V6C 1G8